Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-01
DOI
10.3389/fonc.2021.713853
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331☆
- (2021) D.R. Spigel et al. ANNALS OF ONCOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global Patterns and Trends in Lung Cancer Incidence: A Population-Based Study
- (2021) Yanting Zhang et al. Journal of Thoracic Oncology
- The landscape of immune checkpoints expression in non-small cell lung cancer: a narrative review
- (2021) Yu Liu et al. Translational Lung Cancer Research
- FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III
- (2021) Minlin Jiang et al. Journal for ImmunoTherapy of Cancer
- Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer
- (2021) Peixin Chen et al. Journal for ImmunoTherapy of Cancer
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- High Serum OX40 and OX40 Ligand (OX40L) Levels Correlate with Reduced Survival in Patients with Advanced Lung Adenocarcinoma
- (2020) Jumpei Kashima et al. ONCOLOGY
- RNA sequencing analysis of small cell lung cancer reveals candidate chemotherapy insensitivity long noncoding RNAs and microRNAs
- (2020) Peng Kuang et al. Annals of Translational Medicine
- Elevated TNFRSF4 gene expression is a predictor of poor prognosis in non-M3 acute myeloid leukemia
- (2020) Siyu Gu et al. Cancer Cell International
- An Immunogenomic Investigation of Oral Cavity Squamous Cell Carcinoma in Patients Aged 45 Years and Younger
- (2020) Christopher A. Maroun et al. LARYNGOSCOPE
- Expression of PD-1 and PD-L1 on Tumor-Infiltrating Lymphocytes Predicts Prognosis in Patients with Small-Cell Lung Cancer
- (2020) Chenglong Sun et al. OncoTargets and Therapy
- Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer
- (2020) Peixin Chen et al. Journal for ImmunoTherapy of Cancer
- CD39: the potential target in small cell lung cancer
- (2020) Shanhao Chen et al. Translational Lung Cancer Research
- Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer
- (2020) Yayi He et al. Advanced Science
- Next-generation characterization of the Cancer Cell Line Encyclopedia
- (2019) Mahmoud Ghandi et al. NATURE
- TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma
- (2019) Jason Roszik et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- OX40 and OX40L protein expression of tumor infiltrating lymphocytes in non-small cell lung cancer and its role in clinical outcome and relationships with other immune biomarkers
- (2019) Yayi He et al. Translational Lung Cancer Research
- Immune gene expression in head and neck squamous cell carcinoma patients
- (2019) Charlotte Lecerf et al. EUROPEAN JOURNAL OF CANCER
- Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
- (2019) Luis Paz-Ares et al. LANCET
- High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer
- (2019) Erminia Massarelli et al. Journal for ImmunoTherapy of Cancer
- OX40 Costimulation Inhibits Foxp3 Expression and Treg Induction via BATF3-Dependent and Independent Mechanisms
- (2018) Xiaolong Zhang et al. Cell Reports
- OX40 expression in hepatocellular carcinoma is associated with a distinct immune microenvironment, specific mutation signature, and poor prognosis
- (2018) Kunlin Xie et al. OncoImmunology
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
- (2018) Leora Horn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of the Immune Checkpoint Modulator OX40 in Acute Lymphoblastic Leukemia Is Associated with BCR-ABL Positivity
- (2018) Kathrin Rothfelder et al. NEOPLASIA
- Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study
- (2017) Patrick A. Ott et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune checkpoint inhibition in small cell lung cancer: a key to reach an unmet need?
- (2017) Francesco Gelsomino et al. Translational Cancer Research
- OX40, OX40L and Autoimmunity: a Comprehensive Review
- (2015) Gwilym J. Webb et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy
- (2015) Ichiyo Shibahara et al. Molecular Cancer
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Kaposi Sarcoma of Childhood: Inborn or Acquired Immunodeficiency to Oncogenic HHV-8
- (2015) Carolyn C. Jackson et al. PEDIATRIC BLOOD & CANCER
- OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer
- (2015) Benjamin Weixler et al. Oncotarget
- Small cell lung cancer: Where do we go from here?
- (2014) Lauren Averett Byers et al. CANCER
- ImmPort: disseminating data to the public for the future of immunology
- (2014) Sanchita Bhattacharya et al. IMMUNOLOGIC RESEARCH
- Antagonism of Airway Tolerance by Endotoxin/Lipopolysaccharide through Promoting OX40L and Suppressing Antigen-Specific Foxp3+ T Regulatory Cells
- (2014) W. Duan et al. JOURNAL OF IMMUNOLOGY
- Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) M. Fruh et al. ANNALS OF ONCOLOGY
- Treatment of Small Cell Lung Cancer
- (2013) James R. Jett et al. CHEST
- Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood
- (2013) Minji Byun et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
- (2010) Michael Croft Annual Review of Immunology
- OX40 is required for regulatory T cell–mediated control of colitis
- (2010) Thibault Griseri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The significance of OX40 and OX40L to T-cell biology and immune disease
- (2009) Michael Croft et al. IMMUNOLOGICAL REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now